methylprednisolone has been researched along with Soft Tissue Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biassoni, L; Canavese, G; Coialbu, T; Folco, U; Gatti, C; Giacchero, A; Rosso, R; Toma, S | 1 |
1 trial(s) available for methylprednisolone and Soft Tissue Neoplasms
Article | Year |
---|---|
Epidoxorubicin plus ifosfamide in advanced and/or metastatic soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Ifosfamide; Mesna; Methylprednisolone; Metoclopramide; Middle Aged; Soft Tissue Neoplasms; Time Factors | 1990 |